Resultados de la búsqueda 251-260 of 14229 for Severe malaria

  1. Radiología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to prospectively determine if magnetic resonance imaging (MRI) in patients with cardiac implantable electronic ...

  2. Mayo Clinic Physician Update - January 2025

    Page 1.

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    STAR Trial (Siegel Transcatheter Aortic Valve Replacement In Patients With Symptomatic Severe Aortic Stenosis). Jacksonville, Fla., Rochester, Minn. To ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    ... Chronic Ischemic Stroke ... The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation.

  5. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Methylation And Chromatin Abnormalities In Myelodysplastic Syndromes And Chronic Myelomonocytic Leukemia. Rochester, Minn. The purpose of this study is to ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

  9. Medicina Interna Hospitalaria - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...